BioSpace News Archive

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be presenting at the H.C. Wainwright & Co. 2022 Global Investment Conference.

Biofrontera Inc. announced the closing of its previously-announced $9.4 million private placement with a single institutional investor.

Coinciding with Melanoma Awareness Month, the Melanoma Research Alliance, the largest non-profit funder of melanoma research, announced funding for 27 research grants totaling $13,046,774 to support new research aimed at advancing melanoma prevention, diagnosis and treatment.

Medtronic plc, a global leader in healthcare technology, announced that it will report financial results for its fourth quarter and full fiscal year 2022 on Thursday, May 26, 2022.

The CMD is a live event, open for physical attendance at Hotel Continental in Oslo, Norway, as well as a live webcast.

BiondVax Pharmaceuticals Ltd. announced that it will present in-person at the H.C. Wainwright Global Investment Conference, on May 24, 2022 in Miami, Florida.

CohBar, Inc. announced its virtual participation in the 2022 H.C. Wainwright Global Investment Conference.

Immunovant, Inc. announced that Pete Salzmann, M.D., Chief Executive Officer, will participate in a fireside chat at the UBS Global Healthcare Conference, taking place May 23rd-25th, 2022.

Ryvu Therapeutics, a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, announced that the Company will participate in the following upcoming investors’ conferences.

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today announces that it will present preclinical research supporting its planned second clinical indication, bile duct cancer, also known as cholangiocarcinoma, at the Global Embolization Oncology Symposium.